17 November 2017
News and Views
Links and Services
This month's issue of Gut investigates the effect of aspirin chemoprevention on the recurrence of colorectal adenomas.
Low-dose aspirin reduces the incidence of colorectal cancer and recurrence of adenomas.
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors